Wells Fargo Maintains Delek US(DK.US) With Sell Rating, Raises Target Price to $16
Wells Fargo Sticks to Their Sell Rating for Delek US Holdings (DK)
Delek US Hldgs Analyst Ratings
Morgan Stanley Maintains Underweight on Delek US Hldgs, Lowers Price Target to $18
Delek US Is Maintained at Neutral by Piper Sandler
Piper Sandler Maintains Delek US(DK.US) With Hold Rating, Cuts Target Price to $17
J.P. Morgan Maintains Delek US(DK.US) With Hold Rating, Cuts Target Price to $19
J.P. Morgan Sticks to Their Hold Rating for Delek US Holdings (DK)
Scotiabank Maintains Delek US(DK.US) With Hold Rating, Raises Target Price to $24
Wells Fargo Maintains Underweight on Delek US Hldgs, Lowers Price Target to $15
Delek US Hldgs Analyst Ratings
A Quick Look at Today's Ratings for Delek US(DK.US), With a Forecast Between $15 to $25
Delek US Holdings (DK) Receives a Sell From Wells Fargo
Morgan Stanley Maintains Delek US(DK.US) With Sell Rating, Cuts Target Price to $19
Wells Fargo Maintains Delek US(DK.US) With Sell Rating, Raises Target Price to $17
BofA Securities Maintains Delek US(DK.US) With Sell Rating, Cuts Target Price to $14
Bank of America Securities Sticks to Its Sell Rating for Delek US Holdings (DK)
Delek US Hldgs Analyst Ratings
Morgan Stanley Lowers Price Target on Delek US Holdings to $19 From $21, Keeps Underweight Rating
Mizuho Securities Maintains Delek US(DK.US) With Hold Rating, Announces Target Price $25